ahlam1399
09-11-2015, 11:58 AM
Actelion in talks with ZS Pharma amid surge in biotech deal-making
(Reuters) - Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49c1c05e/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=mGmwYqH5bJU:Ghye2ZQyQ-4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=mGmwYqH5bJU:Ghye2ZQyQ-4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/mGmwYqH5bJU
(Reuters) - Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49c1c05e/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=mGmwYqH5bJU:Ghye2ZQyQ-4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=mGmwYqH5bJU:Ghye2ZQyQ-4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=mGmwYqH5bJU:Ghye2ZQyQ-4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/mGmwYqH5bJU